Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Coronavirus disease - COVID-19 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬Coronavirus disease - COVID-19
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬1. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | Coronavirus disease - COVID-19 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬Coronavirus disease - COVID-19
| Satralizumab | 011 [4] 11, 13, 86, 113 💬2. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Coronavirus disease - COVID-19 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬Coronavirus disease - COVID-19
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬3. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | Cytokine-cytokine receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬Cytokine-cytokine receptor interaction
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬4. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | Cytokine-cytokine receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬Cytokine-cytokine receptor interaction
| Satralizumab | 011 [4] 11, 13, 86, 113 💬5. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Cytokine-cytokine receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬Cytokine-cytokine receptor interaction
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬6. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | Hematopoietic cell lineage 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬Hematopoietic cell lineage
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬7. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Hematopoietic cell lineage 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬Hematopoietic cell lineage
| Satralizumab | 011 [4] 11, 13, 86, 113 💬8. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Hematopoietic cell lineage 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬Hematopoietic cell lineage
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬9. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬HIF-1 signaling pathway
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬10. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬HIF-1 signaling pathway
| Satralizumab | 011 [4] 11, 13, 86, 113 💬11. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬HIF-1 signaling pathway
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬12. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | Human cytomegalovirus infection 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬Human cytomegalovirus infection
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬13. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | Human cytomegalovirus infection 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬Human cytomegalovirus infection
| Satralizumab | 011 [4] 11, 13, 86, 113 💬14. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | Human cytomegalovirus infection 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬Human cytomegalovirus infection
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬15. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | JAK-STAT signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬JAK-STAT signaling pathway
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬16. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | JAK-STAT signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬JAK-STAT signaling pathway
| Satralizumab | 011 [4] 11, 13, 86, 113 💬17. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 | JAK-STAT signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬JAK-STAT signaling pathway
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬18. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 | Non-alcoholic fatty liver disease 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬Non-alcoholic fatty liver disease
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬19. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 | Non-alcoholic fatty liver disease 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬Non-alcoholic fatty liver disease
| Satralizumab | 011 [4] 11, 13, 86, 113 💬20. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 | Non-alcoholic fatty liver disease 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬Non-alcoholic fatty liver disease
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬21. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬Pathways in cancer
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬22. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬Pathways in cancer
| Satralizumab | 011 [4] 11, 13, 86, 113 💬23. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬Pathways in cancer
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬24. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬PI3K-Akt signaling pathway
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬25. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬PI3K-Akt signaling pathway
| Satralizumab | 011 [4] 11, 13, 86, 113 💬26. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬PI3K-Akt signaling pathway
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬27. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
28 | Th17 cell differentiation 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬Th17 cell differentiation
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬28. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
29 | Th17 cell differentiation 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬Th17 cell differentiation
| Satralizumab | 011 [4] 11, 13, 86, 113 💬29. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
30 | Th17 cell differentiation 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬Th17 cell differentiation
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬30. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬Viral protein interaction with cytokine and cytokine receptor
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬31. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
32 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬Viral protein interaction with cytokine and cytokine receptor
| Satralizumab | 011 [4] 11, 13, 86, 113 💬32. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 3 drugs (DrugBank) and 26 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬Viral protein interaction with cytokine and cytokine receptor
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬33. Viral protein interaction with cytokine and cytokine receptor
|
Coronavirus disease - COVID-19
1 gene, 3 drugs (DrugBank) and 26 diseases
Cytokine-cytokine receptor interaction
1 gene, 3 drugs (DrugBank) and 26 diseases
Hematopoietic cell lineage
1 gene, 3 drugs (DrugBank) and 26 diseases
HIF-1 signaling pathway
1 gene, 3 drugs (DrugBank) and 26 diseases
Human cytomegalovirus infection
1 gene, 3 drugs (DrugBank) and 26 diseases
JAK-STAT signaling pathway
1 gene, 3 drugs (DrugBank) and 26 diseases
Non-alcoholic fatty liver disease
1 gene, 3 drugs (DrugBank) and 26 diseases
Pathways in cancer
1 gene, 3 drugs (DrugBank) and 26 diseases
PI3K-Akt signaling pathway
1 gene, 3 drugs (DrugBank) and 26 diseases
Th17 cell differentiation
1 gene, 3 drugs (DrugBank) and 26 diseases
Viral protein interaction with cytokine and cytokine receptor
1 gene, 3 drugs (DrugBank) and 26 diseases